E. Rand Sutherland
CEO & DirectorDr. E. Rand Sutherland, MD, MPH, has been a Director of Krystal Biotech, Inc. from January 2022. Dr. Sutherland serves as Chief Executive Officer and Director at Upstream Bio, Inc. since April 2024. Dr. Sutherland was Chief Executive Officer of Seeker Biologics. Prior to joining Seeker Biologics, Dr. Sutherland was President of Translate Bio, where he was responsible for research and development, corporate development, portfolio strategy and program management, from March 2021 until the company’s acquisition in September 2021. Before joining Translate Bio, Dr. Sutherland spent years at Sanofi, most recently as Senior Vice President and Global Head of Medical Affairs for Sanofi Genzyme and prior to that, Head of Rare Diseases Development. Dr. Sutherland’s strategic leadership in clinical development and medical affairs has been critical to the development and launch of medicines for lysosomal storage diseases, rare blood and other genetic diseases and pulmonary and immunological diseases. Before joining the biopharmaceutical industry, Dr. Sutherland was Professor of Medicine at the University of Colorado and Chief of Pulmonary and Critical Care Medicine at National Jewish Health in Denver, where he cared for patients and led an NIH-funded clinical and translational research program focused on severe asthma and other complicated pulmonary diseases. Dr. Sutherland is an independent director of Vanqua Bio, Inc. and Allakos Inc. Dr. Sutherland holds a BA with honors from Oberlin College, an MPH from the Harvard School of Public Health and an MD with honors from the University of Chicago. He completed his post-doctoral training in Internal Medicine at the University of California, San Francisco, where he also served as Chief Medical Resident, followed by a fellowship in Pulmonary and Critical Care Medicine at the University of Colorado.
Positions
- Company NameUpstream Bio, Inc.Stock CodeUPBPositionCEO & DirectorColleagues
- RCRonald C. RenaudIndependent Chairman of the Board
- MPMichael Paul GrayCFO & COO
- ADAaron DeykinChief Medical Officer and Head of Research & Development
- SPStacy PriceChief Technology Officer
- MBMeggan BuckwellDirector of Corporate Communications & Investor Relations
- MKMarcella Kuhlman RuddyIndependent Director
- DBDaniella BeckmanIndependent Director
- ECErez ChimovitsIndependent Director
